Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Collaboration revenue	$ 410	$ 468
Operating expenses:
Research and development	12,596	8,505
General and administrative	5,127	3,888
Total operating expenses	17,723	12,393
Loss from operations	(17,313)	(11,925)
Other income:
Interest income	1,072	14
Total other income	1,072	14
Loss before income tax expense	(16,241)	(11,911)
Income tax expense	(14)
Net loss	(16,255)	(11,911)
Unrealized holding loss on short-term investments, net of tax	(22)
Comprehensive loss	$ (16,277)	$ (11,911)
Net loss per share attributable to common stockholders- basic	$ (0.44)	$ (0.92)
Net loss per share attributable to common stockholders- diluted	$ (0.44)	$ (0.92)
Weighted-average common shares outstanding-basic	36,832,747	13,008,779
Weighted-average common shares outstanding-diluted	36,832,747	13,008,779